Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice

被引:27
作者
Dong, Ai-Qiang
Kong, Min-Han
Ma, Zhi-Yuan
Qian, Jian-Fang
Xu, Xiao-Hong [1 ]
机构
[1] Zhejiang Univ, Sch Med, Dept Endocrinol, Affiliated Hosp 2, Hangzhou 310009, Peoples R China
[2] Zhejiang Univ, Sch Med, Dept Cardiothorac Surg, Affiliated Hosp 2, Hangzhou 310009, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Affiliated Peoples Hosp 1, Shanghai 200080, Peoples R China
基金
美国国家科学基金会;
关键词
lung cancer; type 1 insulin-like growth factor receptor; RNA interference;
D O I
10.1016/j.cellbi.2006.11.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Type I insulin-like growth factor receptor (IGF-IR), which is frequently overexpressed in a variety of human cancers including lung cancer, mediates cancer cell proliferation and tumor growth. In this study, we used a human U6 promoter-driven DNA-template approach to induce hairpin RNA (hpRNA)-triggered RNAi to silence IGF-IR gene expression in the human lung cancer cell line A549, and then evaluate its effects on apoptosis, apoptosis-related gene expression, and the growth of tumor cells in vitro and in nude mice. IGF-IR expression levels were found to markedly decrease in cells transfected with a plasmid expressing hairpin siRNA for IGF-IR (by more than 78.9%). Down-regulation of IGR-IR concomitantly accompanied reduction of bcl-2 as well as pERK and pAkt levels, activation of caspase-3, apoptosis and growth inhibition of A549 cells in vitro. Direct intratumoral injections of plasmid DNA expressing hpRNA for IGF-IR significantly regressed pre-established tumors in nude mice. Our results support the therapeutic potential of RNAi as a method for gene therapy in treating lung cancer. (C) 2006 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:500 / 507
页数:8
相关论文
共 33 条
[1]   RNAi and related mechanisms and their potential use for therapy [J].
Agami, R .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (06) :829-834
[2]  
Beech DJ, 2001, ONCOL REP, V8, P325
[3]   ONCOGENES AND SIGNAL TRANSDUCTION [J].
CANTLEY, LC ;
AUGER, KR ;
CARPENTER, C ;
DUCKWORTH, B ;
GRAZIANI, A ;
KAPELLER, R ;
SOLTOFF, S .
CELL, 1991, 64 (02) :281-302
[4]   Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo [J].
Chernicky, CL ;
Yi, LJ ;
Tan, HQ ;
Gan, SU ;
Ilan, J .
CANCER GENE THERAPY, 2000, 7 (03) :384-395
[5]   RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase -: art. no. e46 [J].
Donzé, O ;
Picard, D .
NUCLEIC ACIDS RESEARCH, 2002, 30 (10) :e46
[6]  
Dunn SE, 1998, CANCER RES, V58, P3353
[7]   Lung cancer [J].
Evans, TL ;
Lynch, TJ .
ONCOLOGIST, 2001, 6 (05) :407-414
[8]   A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts [J].
Goetsch, L ;
Gonzalez, A ;
Leger, O ;
Beck, A ;
Pauwels, PJ ;
Haeuw, JF ;
Corvaia, N .
INTERNATIONAL JOURNAL OF CANCER, 2005, 113 (02) :316-328
[9]   Cancer statistics, 2000 [J].
Greenlee, RT ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2000, 50 (01) :7-33
[10]   Treatment of advanced non-small cell lung cancer - Should include short courses of radiation, with palliation as the aim [J].
Hansen, HH .
BRITISH MEDICAL JOURNAL, 2002, 325 (7362) :452-453